These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34454465)

  • 1. Evaluation of the effect of multipoint intra-mucosal vaginal injection of a specific cross-linked hyaluronic acid for vulvovaginal atrophy: a prospective bi-centric pilot study.
    Berreni N; Salerno J; Chevalier T; Alonso S; Mares P
    BMC Womens Health; 2021 Aug; 21(1):322. PubMed ID: 34454465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study.
    De Seta F; Caruso S; Di Lorenzo G; Romano F; Mirandola M; Nappi RE
    Maturitas; 2021 May; 147():34-40. PubMed ID: 33832645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injection Treatments for Vulvovaginal Atrophy of Menopause: A Systematic Review.
    Moccia F; Pentangelo P; Ceccaroni A; Raffone A; Losco L; Alfano C
    Aesthetic Plast Surg; 2023 Dec; 47(6):2788-2799. PubMed ID: 37580562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of injecting platelet concentrate combined with hyaluronic acid for the treatment of vulvovaginal atrophy in postmenopausal women with history of breast cancer: a phase 2 pilot study.
    Hersant B; SidAhmed-Mezi M; Belkacemi Y; Darmon F; Bastuji-Garin S; Werkoff G; Bosc R; Niddam J; Hermeziu O; La Padula S; Meningaud JP
    Menopause; 2018 Oct; 25(10):1124-1130. PubMed ID: 29738415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the Benefits of CO
    Jankovic S; Rovcanin M; Tomic A; Jurisic A; Milovanovic Z; Zamurovic M
    Medicina (Kaunas); 2024 Jun; 60(7):. PubMed ID: 39064488
    [No Abstract]   [Full Text] [Related]  

  • 6. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
    Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
    J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycarbophil vaginal moisturizing gel versus hyaluronic acid gel in women affected by vaginal dryness in late menopausal transition: A prospective randomized trial.
    Cagnacci A; Barattini DF; Casolati E; Pecoroni A; Mangrella M; Patrascu LC
    Eur J Obstet Gynecol Reprod Biol; 2022 Mar; 270():239-245. PubMed ID: 35131532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal natural oxygenation device (VNOD) for concomitant administration of hyaluronic acid and topical hyperbaric oxygen to treat vulvo-vaginal atrophy: a pilot study.
    Condemi L; Di Giuseppe J; Delli Carpini G; Garoia F; Frega A; Ciavattini A
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8480-8486. PubMed ID: 30556890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyspareunia Related to GSM: Association of Total Vaginal Thickness via Transabdominal Ultrasound.
    Balica AC; Cooper AM; McKevitt MK; Schertz K; Wald-Spielman D; Egan S; Bachmann GA
    J Sex Med; 2019 Dec; 16(12):2038-2042. PubMed ID: 31542351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women.
    Nappi RE; Kotek M; Brešt'anský A; Giordan N; Tramentozzi E
    Climacteric; 2020 Oct; 23(5):519-524. PubMed ID: 32396754
    [No Abstract]   [Full Text] [Related]  

  • 13. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
    Kingsberg SA; Wysocki S; Magnus L; Krychman ML
    J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intradermal hyaluronic acid plus polynucleotides in vulvovaginal atrophy: a pilot study.
    Angelucci M; Frascani F; Franceschelli A; Lusi A; Garo ML
    Climacteric; 2022 Oct; 25(5):490-496. PubMed ID: 35389304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol softgel inserts for the treatment of VVA symptoms: an expert opinion.
    Liu JH; Bernick B; Mirkin S
    Expert Opin Drug Deliv; 2020 Nov; 17(11):1573-1581. PubMed ID: 32877254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic Acid in Postmenopause Vaginal Atrophy: A Systematic Review.
    Dos Santos CCM; Uggioni MLR; Colonetti T; Colonetti L; Grande AJ; Da Rosa MI
    J Sex Med; 2021 Jan; 18(1):156-166. PubMed ID: 33293236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attitudes and perceptions towards vulvar and vaginal atrophy in Italian post-menopausal women: Evidence from the European REVIVE survey.
    Nappi RE; Particco M; Biglia N; Cagnacci A; Di Carlo C; Luisi S; Paoletti AM
    Maturitas; 2016 Sep; 91():74-80. PubMed ID: 27451324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-week treatment with fractional CO2 laser for vulvovaginal atrophy: a pilot study.
    Salvatore S; Nappi RE; Zerbinati N; Calligaro A; Ferrero S; Origoni M; Candiani M; Leone Roberti Maggiore U
    Climacteric; 2014 Aug; 17(4):363-9. PubMed ID: 24605832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.
    Pinkerton JV; Bushmakin AG; Komm BS; Abraham L
    Maturitas; 2017 Jun; 100():57-63. PubMed ID: 28539177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, multicenter, uncontrolled study on the effectiveness and safety of a hyaluronic acid water-based vaginal lubricant in alleviating vaginal dryness and dyspareunia.
    Sánchez-Prieto M; Pingarrón C; Bergamaschi L; Bermúdez JC; Subiris González J; Sánchez Sánchez R; Poyo Torcal S; Gómez M; Ruiz Pérez ML; Castillo Martínez M; Peña Penedo ME; Sánchez-Borrego R
    Gynecol Endocrinol; 2024 Mar; 40(1):2317268. PubMed ID: 38468593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.